NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2026
Voltar para busca
Dado oficial do USPTO
RADDISH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
RADDISH
ST13
US500000098116944Classe
35, 36, 42, 44
Pedido
98116944
Registro
8254423
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
12/05/2026
Tipo de marca
Verbal
Classes Nice
35, 36, 42, 44
Data de depósito
04/08/2023
Data de registro
12/05/2026
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/05/2026
Última transação
12/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
30/06/2025
Primeiro uso no comércio
30/06/2025
Código do desenho
4
Tipo de titular
03
Localização do titular
Washington, DC, US
Examinador
CHONG, JESSICA EUNKYO
Unidade examinadora
L50
Localização atual
TMEG LAW OFFICE 105
Titulares e representantes
Titulares
Global Alzheimer's Platform Foundation Inc.
Representantes
Christopher A. Proskey BROWNWINICK LAW FIRM
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Promoting public awareness of Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registriespatient researchpatient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseasesthe importance of patient registration on Alzheimer'sneurodegenerative diseases and other neurological and central nervous system disease registries; Charitable servicesorganizing and developing programs that aim to improve the lives of patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system disease patientstheir caregivers and families; Charitable business servicesadministration of programs for enabling participants to receive services for Alzheimer'sneurodegenerative diseases and other neurological and central nervous system disease patientstheir caregivers and families; Business servicesrecruitment of participants for neuroscience clinical research; Maintaining a registry of participants for neuroscience clinical research relating to the treatment and prevention of brain disease; Promoting participation in clinical trials and research in the neuroscience field; Recruitment advertising servicesadvertising clinical trials for the purpose of recruiting patients and placing patients for participation in clinical trials in the neuroscience field
Classe 36
Charitable fundraising; Charitable fundraising for Alzheimer's disease and neurodegenerative disease research and treatment
Classe 42
Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer'sneuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific researchconducting clinical trials for others; Medical and scientific researchconducting clinical trials for patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases
Classe 44
Healthcare services; Healthcare servicesadministering care to patients; Healthcare servicesadministering care to patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases; Healthcare servicesadministering tests for patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases; Healthcare servicestaking samples from patients with Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases; Establishing tissuebloodsorganstem cell bank of biological samples related to Alzheimer's neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer'sneurodegenerative diseasesother neurological and central nervous system diseases; Providing health screening services related to Alzheimer'sneurodegenerative diseases and other neurological and central nervous system diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
17/04/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17/04/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/04/2026
IUAF
USE AMENDMENT FILED
14/10/2025
EISU
TEAS STATEMENT OF USE RECEIVED
14/10/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/04/2025
EX1G
SOU EXTENSION 1 GRANTED
12/04/2025
EXT1
SOU EXTENSION 1 FILED
11/04/2025
EEXT
SOU TEAS EXTENSION RECEIVED
11/04/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/08/2024
PUBO
PUBLISHED FOR OPPOSITION
20/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
16/07/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/07/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
16/07/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/07/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2024
GNRT
NON-FINAL ACTION E-MAILED
08/04/2024
CNRT
NON-FINAL ACTION WRITTEN
08/04/2024
DOCK
ASSIGNED TO EXAMINER
05/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2023
NWAP
NEW APPLICATION ENTERED
08/08/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RADDISH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.